Supplemental Material: Histopathological predictors of immune-related adverse events among patients with melanoma treated with immune checkpoint inhibitors

Published: 22 November 2023| Version 1 | DOI: 10.17632/nxp4xwy8hz.1
Contributors:
Catherina Pan, Mofei Liu, Charles Lau, William Lau, Daniel Kim, Rachael Rowley, Ruhi Kanwar, Anita Giobbie-Hurder, Nicole LeBoeuf, Vinod Nambudiri

Description

Supplementary tables for JAAD research letter titled "Histopathological predictors of immune-related adverse events among patients with melanoma treated with immune checkpoint inhibitors"

Files

Institutions

  • Brigham and Women's Hospital
  • Boston University
  • Dana Farber Cancer Institute
  • Harvard Medical School
  • Boston University School of Medicine

Categories

Histopathology, Adverse Event, Melanoma, Immune Checkpoint Inhibitor

Licence